We have found 817 companies that use Illumina DNA Sequencing. Our data for Illumina DNA Sequencing usage goes back as far as 1 years and 5 months.
58% of Illumina DNA Sequencing customers are in United States and 6% are in United Kingdom. Of all the companies that are using Illumina DNA Sequencing, 18% are small (<50 employees), 30% are medium-sized and 46% are large (>1000 employees). Looking at Illumina DNA Sequencing customers by industry, we find that Higher Education (26%), Hospital & Health Care (21%), Biotechnology (11%) and Research (8%) are the largest segments.
|Logo||Company||Website||Signal Strength||Scan Date|
|THE BROAD INSTITUTE, INC.||broadinstitute.org||2017-06-23|
|Baylor College of Medicine||bcm.edu||2017-06-23|
We use the best scanning techniques combined with advanced data science to monitor the market share of over 5,000 technology products, including Healthcare. In the Healthcare category, Illumina DNA Sequencing has a market share of about 1.2%. Other major and competing products in this category include:
For DNA sequencing, Illumina's next-generation sequencing (NGS) technology uses clonal amplification and sequencing by synthesis (SBS) chemistry to enable rapid, accurate sequencing. The process simultaneously identifies DNA bases while incorporating them into a nucleic acid chain.